Global Home Global Home  
 
 

 

 

Press Releases

= Add Release to Briefcase

DATE

TITLE

 
Apr 17, 2018 Sonoma Pharmaceuticals Receives Four New UAE Regulatory Approvals that Include Acne and Anti-Fungal Products PDF 19.4 KB Add to Briefcase
 
 
Apr 5, 2018 Sonoma Pharmaceuticals Announces FDA Approval for Antimicrobial Post-Therapy Gel PDF 20.5 KB Add to Briefcase
 
 
Mar 27, 2018 Sonoma Pharmaceuticals Introduces New and Improved Acuicyn™ Antimicrobial Eyelid and Eyelash Hygiene Solution PDF 20.1 KB Add to Briefcase
 
 
Mar 9, 2018 Sonoma Pharmaceuticals to Present at Roth Capital Partners 30th Annual Growth Stock Conference on March 13, 2018 PDF 18.7 KB Add to Briefcase
 
 
Mar 6, 2018 Sonoma Pharmaceuticals Announces Closing of $5 Million Public Offering of Common Stock PDF 20.0 KB Add to Briefcase
 
 
Mar 2, 2018 Sonoma Pharmaceuticals Announces Pricing of $5 Million Public Offering of Common Stock PDF 19.2 KB Add to Briefcase
 
 
Feb 7, 2018 Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46% PDF 51.5 KB Add to Briefcase
 
 
Jan 25, 2018 Sonoma Pharmaceuticals Announces Fiscal Third Quarter 2018 Financial Results and Conference Call PDF 17.2 KB Add to Briefcase
 
 
Jan 9, 2018 Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn® for Management of Blepharitis, Microsafe® Oral Care for Mucositis and Sinudox® for Chronic Sinusitis PDF 21.7 KB Add to Briefcase
 
 
Dec 5, 2017 Sonoma Pharmaceuticals Announces Second FDA Approval to Add Antimicrobial Language to Alevicyn™ Gel Products for Management of Atopic Dermatitis PDF 19.8 KB Add to Briefcase
 

Showing 1-10 of 79

Page: 1 2 3 ... 8

 Next 10